Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 7.

Lalaoui, N; Hänggi, K; Brumatti, G; Chau, D; Nguyen, N Y N; Vasilikos, L; Spilgies, L M; Heckmann, D A; Ma, C; Ghisi, M; Salmon, J M; Matthews, G M; de Valle, E; Moujalled, D M; Menon, M B; Spall, S K; Glaser, S P; Richmond, J; Lock, R B; Condon, S M; Gugasyan, R; Gaestel, M; Guthridge, M; Johnstone, R W; Munoz, L; Wei, A; Ekert, P G; Vaux, D L; Wong, W Wei-Lynn; Silke, J (2016). Targeting p38 or MK2 enhances the anti-leukemic activity of smac-mimetics. Cancer Cell, 29(2):145-158.

Etemadi, N; Chopin, M; Anderton, H; Tanzer, M C; Rickard, J A; Abeysekra, W; Hall, C; Spall, S K; Wang, B; Xiong, Y; HLa, T; Pitson, S M; Bonder, C S; Wong, W W; Ernst, M; Smyth, G K; Vaux, D L; Nutt, S L; Nachbur, U; Silke, J (2015). TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase-1. eLife, 4:e10592.

Moulin, M; Anderton, H; Voss, A K; Thomas, T; Wong, W W L; Bankovacki, A; Feltham, R; Chau, D; Cook, W D; Silke, J; Vaux, D L (2012). IAPs must limit activation of RIP kinases by TNF Receptor 1 to prevent embryonic lethality. EMBO Journal Online, 31(7):1679-1691.

Gentle, I E; Wong, W W L; Evans, J M; Bankovacki, A; Cook, W D; Khan, N R; Nachbur, U; Rickard, J; Anderton, H; Moulin, M; Lluis, J M; Moujalled, D M; Silke, J; Vaux, D L (2011). In TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-kappaB and activation of caspase-8. Journal of Biological Chemistry, 286(15):13282-13291.

Wong, W Wei-Lynn; Gentle, I G; Nachbur, U; Carter, H; Vaux, D L; Silke, J (2010). RIPK1 is not essential for TNFR1-induced activation of NF-κB. Cell Death and Differentiation, 17:482-487.

Lluis, J M; Nachbur, U; Cook, W D; Gentle, I E; Moujalled, D; Moulin, M; Wong, W W L; Khan, N; Chau, D; Callus, B A; Vince, J E; Silke, J; Vaux, D L (2010). TAK1 is required for survival of mouse fibroblasts treated with TRAIL, and does so by NF-kappaB dependent induction of cFLIPL. PLoS ONE, 5(1):e8620.

Vince, J E; Pantaki, D; Feltham, R; Mace, P D; Cordier, S M; Schmukle, A C; Davidson, A J; Callus, B A; Wong, W Wei-Lynn; Gentle, I E; Carter, H; Lee, E F; Walczak, H; Day, C L; Vaux, D L; Silke, J (2009). TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced apoptosis. Journal of Biological Chemistry, 284(51):35906-35915.

This list was generated on Fri Nov 24 13:47:08 2017 CET.